Literature DB >> 21365223

Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.

Dorota Latek1, Michal Kolinski, Umesh Ghoshdastider, Aleksander Debinski, Rafal Bombolewski, Anita Plazinska, Krzysztof Jozwiak, Slawomir Filipek.   

Abstract

Cannabinoid and adrenergic receptors belong to the class A (similar to rhodopsin) G protein coupled receptors. Docking of agonists and antagonists to CB(1) and CB(2) cannabinoid receptors revealed the importance of a centrally located rotamer toggle switch and its possible participation in the mechanism of agonist/antagonist recognition. The switch is composed of two residues, F3.36 and W6.48, located on opposite transmembrane helices TM3 and TM6 in the central part of the membranous domain of cannabinoid receptors. The CB(1) and CB(2) receptor models were constructed based on the adenosine A(2A) receptor template. The two best scored conformations of each receptor were used for the docking procedure. In all poses (ligand-receptor conformations) characterized by the lowest ligand-receptor intermolecular energy and free energy of binding the ligand type matched the state of the rotamer toggle switch: antagonists maintained an inactive state of the switch, whereas agonists changed it. In case of agonists of β(2)AR, the (R,R) and (S,S) stereoisomers of fenoterol, the molecular dynamics simulations provided evidence of different binding modes while preserving the same average position of ligands in the binding site. The (S,S) isomer was much more labile in the binding site and only one stable hydrogen bond was created. Such dynamical binding modes may also be valid for ligands of cannabinoid receptors because of the hydrophobic nature of their ligand-receptor interactions. However, only very long molecular dynamics simulations could verify the validity of such binding modes and how they affect the process of activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365223     DOI: 10.1007/s00894-011-0986-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  57 in total

1.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation.

Authors:  Olaf Fritze; Sławomir Filipek; Vladimir Kuksa; Krzysztof Palczewski; Klaus Peter Hofmann; Oliver P Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

2.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  Protein structure modeling with MODELLER.

Authors:  Narayanan Eswar; David Eramian; Ben Webb; Min-Yi Shen; Andrej Sali
Journal:  Methods Mol Biol       Date:  2008

5.  Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics.

Authors:  Tod D Romo; Alan Grossfield; Michael C Pitman
Journal:  Biophys J       Date:  2010-01-06       Impact factor: 4.033

6.  Crystal structure of the ligand-free G-protein-coupled receptor opsin.

Authors:  Jung Hee Park; Patrick Scheerer; Klaus Peter Hofmann; Hui-Woog Choe; Oliver Peter Ernst
Journal:  Nature       Date:  2008-06-18       Impact factor: 49.962

7.  Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.

Authors:  P Gouldson; B Calandra; P Legoux; A Kernéis; M Rinaldi-Carmona; F Barth; G Le Fur; P Ferrara; D Shire
Journal:  Eur J Pharmacol       Date:  2000-07-28       Impact factor: 4.432

8.  Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.

Authors:  Anthony Yiu-Ho Woo; Tian-Bing Wang; Xiaokun Zeng; Weizhong Zhu; Darrell R Abernethy; Irving W Wainer; Rui-Ping Xiao
Journal:  Mol Pharmacol       Date:  2008-10-07       Impact factor: 4.436

9.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

10.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.

Authors:  K Wieland; H M Zuurmond; C Krasel; A P Ijzerman; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

View more
  12 in total

1.  Deletion of Type-2 Cannabinoid Receptor Induces Alzheimer's Disease-Like Tau Pathology and Memory Impairment Through AMPK/GSK3β Pathway.

Authors:  Lin Wang; Bing-Jin Liu; Yun Cao; Wei-Qi Xu; Dong-Sheng Sun; Meng-Zhu Li; Fang-Xiao Shi; Man Li; Qing Tian; Jian-Zhi Wang; Xin-Wen Zhou
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 2.  New Insights in Cannabinoid Receptor Structure and Signaling.

Authors:  Lingyan Ye; Zheng Cao; Weiwei Wang; Naiming Zhou
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

3.  Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.

Authors:  Pankaj Pandey; Kuldeep K Roy; Robert J Doerksen
Journal:  J Biomol Struct Dyn       Date:  2019-02-05

Review 4.  Action of molecular switches in GPCRs--theoretical and experimental studies.

Authors:  B Trzaskowski; D Latek; S Yuan; U Ghoshdastider; A Debinski; S Filipek
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

5.  Discovery of Selective Cannabinoid CB2 Receptor Agonists by High-Throughput Screening.

Authors:  Lisa M Ogawa; Neil T Burford; Yu-Hsien Liao; Caitlin E Scott; Ashley M Hine; Craig Dowling; Jefferson Chin; Mike Power; Edward J Hunnicutt; Victoria L Emerick; Martyn Banks; Litao Zhang; Samuel W Gerritz; Andrew Alt; Debra A Kendall
Journal:  SLAS Discov       Date:  2017-12-19       Impact factor: 3.341

6.  Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs.

Authors:  Zhiwei Feng; Mohammed Hamed Alqarni; Peng Yang; Qin Tong; Ananda Chowdhury; Lirong Wang; Xiang-Qun Xie
Journal:  J Chem Inf Model       Date:  2014-09-05       Impact factor: 4.956

Review 7.  Cannabinoids and Cannabinoid Receptors: The Story so Far.

Authors:  Fred Shahbazi; Victoria Grandi; Abhinandan Banerjee; John F Trant
Journal:  iScience       Date:  2020-06-20

8.  Virtual Screening of C. Sativa Constituents for the Identification of Selective Ligands for Cannabinoid Receptor 2.

Authors:  Mikołaj Mizera; Dorota Latek; Judyta Cielecka-Piontek
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

9.  Drug-induced diabetes type 2: In silico study involving class B GPCRs.

Authors:  Dorota Latek; Ewelina Rutkowska; Szymon Niewieczerzal; Judyta Cielecka-Piontek
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

10.  The Hydrophobic Ligands Entry and Exit from the GPCR Binding Site-SMD and SuMD Simulations.

Authors:  Jakub Jakowiecki; Urszula Orzeł; Sathapana Chawananon; Przemysław Miszta; Sławomir Filipek
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.